Qilu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is OXALIPLATIN USP (NON-STERILE API), with a corresponding US DMF Number 23530.
Remarkably, this DMF maintains an Active status since its submission on February 08, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 15, 2013, and payment made on September 06, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II